Bio-Accu Rapid Test Kits
FDA-cleared rapid test kits across four panels, made in the USA.
- Clearance
- FDA cleared
- Origin
- Made in USA
- Experience
- 20+ years
- Availability
- In stock
What it is
Bio-Accu rapid tests span fertility, infectious disease, tumour markers and drugs of abuse — held in stock and made in the USA by a manufacturer with over twenty years in test kit production. Formats include device, strip and stick, on urine, serum or plasma depending on the assay.
Indications
- Fertility — hCG pregnancy and ovulation prediction
- Infectious disease — Chlamydia, Strep A, Rubella, Mononucleosis, Lyme, H. pylori, HIV-1/HIV-2, Hepatitis B surface antigen, Chagas, Salmonella
- Tumour markers — PSA, AFP, CEA, faecal occult blood
- Drugs of abuse — COC, opiates/morphine, THC, MET, AMP, BAR, BZO, methadone, and 2/4/6-panel DOA
Specifications & configurations
Manufacturer documentation for Bio-Accu Rapid Test Kits. Click any image to open it full size.
Key features
Four panels, one supplier
Fertility, infectious disease, tumour markers and drug testing from a single source, which simplifies ordering for a practice running more than one screening programme.
Multiple sample types and formats
Device, strip and stick formats across urine, serum and plasma — chosen per assay rather than forced into one platform.
Domestic manufacturing, held in stock
Made in the USA with over twenty years of test kit manufacturing behind it, and carried in stock for prompt fulfilment.
The underlying principle
Lateral-flow immunoassay. Sample migrates along a nitrocellulose membrane where labelled antibodies bind the target analyte and concentrate at a test line, giving a visual result without instrumentation — which is what makes these viable at the point of care.
Clearance & regulatory position
Bio-Med USA distributes FDA-cleared medical, aesthetic, surgical and dental devices. Clearance numbers, indications-for-use statements and the current regulatory position for Bio-Accu Rapid Test Kits in your market are provided on request.
